Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “Labels”
Open-label Extension of the HOPE-2 Trial
ClinicalTrials.gov study NCT04428476. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label Extension of EryDex Study IEDAT-04-2022
ClinicalTrials.gov study NCT06664853. IPD Sharing: NO. Countries: 9. Publications: 0.
Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies
ClinicalTrials.gov study NCT01625338. IPD Sharing: Not stated. Countries: 16. Publications: 0.
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated
ClinicalTrials.gov study NCT02512068. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02961881. IPD Sharing: YES. Countries: 6. Publications: 0.
Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan® in Subjects With Phenylketonuria
ClinicalTrials.gov study NCT01732471. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma
ClinicalTrials.gov study NCT01290887. IPD Sharing: Not stated. Countries: 31. Publications: 0.
An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive Method
ClinicalTrials.gov study NCT00653016. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial
ClinicalTrials.gov study NCT00407797. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01077622. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT04195698. IPD Sharing: YES. Countries: 22. Publications: 0.
A Single-Center Open-Label Study of 1064 nm for Nonablative Skin Rejuvenation
ClinicalTrials.gov study NCT03421691. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mg
ClinicalTrials.gov study NCT02712320. IPD Sharing: NO. Countries: 1. Publications: 0.
TMC125-C227: A Phase II Randomized, Active-Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-Naive and With Documented Genotypi
ClinicalTrials.gov study NCT00225303. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis
ClinicalTrials.gov study NCT00617994. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension
ClinicalTrials.gov study NCT01027949. IPD Sharing: NO. Countries: 20. Publications: 0.
Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer
ClinicalTrials.gov study NCT04529850. IPD Sharing: NO. Countries: 6. Publications: 0.
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers
ClinicalTrials.gov study NCT01767103. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)
ClinicalTrials.gov study NCT00465088. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect
ClinicalTrials.gov study NCT03028103. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.